(Q41454449)

30 September 2017

title

Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination (English)

1 reference

30 September 2017

1 reference

3

1 reference

30 September 2017

author name string

Rebecca J Critchley-Thorne

series ordinal

1

1 reference

30 September 2017

Andrew J Stagg

series ordinal

2

1 reference

30 September 2017

publication date

11 April 2006

1 reference

30 September 2017

1 reference

30 September 2017

volume

14

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

183-191

1 reference

Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Oral somatic transgene vaccination using attenuated S. typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

An autologous oral DNA vaccine protects against murine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Bacteria-mediated DNA transfer in gene therapy and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Bacterial gene therapy strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

How intestinal epithelial cell differentiation inhibits the cell-entry of Yersinia pseudotuberculosis in colon carcinoma Caco-2 cell line in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Exploiting M cells for drug and vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Delivery of protein to the cytosol of macrophages using Escherichia coli K-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Functional gene transfer from intracellular bacteria to mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Potential therapeutic applications of recombinant, invasive E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Engineered E. coli delivers therapeutic genes to the colonic mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Mucosal immunity and tolerance: relevance to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

The role of dendritic cells in antigen processing in the Peyer's patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Measurement of invasion by gentamicin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

Cellular characterization of the tropism of recombinant adenovirus for the adrenal glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.01.011

1 reference

30 September 2017

1 reference